Hospital
Maple Grove Hospital Corporation
Maple Grove Hospital Corporation was paid $7.58M by Medicaid between Jan 2018 and Nov 2024, across 51 billing codes. Its largest line is 99284, emergency room visit (serious) — 66% of everything it billed.
33Billing provider infoMAPLE GROVE HOSPITAL CORPORATION
MAPLE GROVE, MN 55369
MAPLE GROVE, MN 55369
33aNPI1225272552assigned 04/30/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.58M
24GClaims106,113
24DCodes billed51
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Minnesota
Rank by total paid#21 of 36
Median peer was paid$11.46M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GALE, STEPHANIE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,873 | $454K | |
| 2019 | 12,188 | $1.02M | |
| 2020 | 9,318 | $826K | |
| 2021 | 16,532 | $1.50M | |
| 2022 | 15,883 | $1.39M | |
| 2023 | 16,886 | $1.27M | |
| 2024incomplete | 12,433 | $1.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 66% | 20,544 | 19,176 | $4.97M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 8,810 | 8,358 | $977K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.2% | 4,900 | 4,737 | $547K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.3% | 1,850 | 1,569 | $248K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 1,787 | 1,661 | $206K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 16,685 | 15,158 | $159K |
| 99460 | 1.1% | 1,509 | 1,490 | $83K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,174 | 1,111 | $68K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 426 | 419 | $58K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,084 | 1,068 | $46K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 948 | 429 | $38K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,701 | 2,558 | $37K |
39 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,331 | $25K |
| 99223 | Prolong inpt eval add15 m | <1% | 162 | $21K |
| 99464 | <1% | 514 | $17K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 386 | $16K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 126 | $15K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 22,799 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 348 | $7K |
| 99462 | <1% | 240 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 68 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,932 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 105 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 30 | $3K |
| 99217 | <1% | 39 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 23 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 13 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 170 | $1K |
| G0378 | Hospital observation service, per hour | <1% | 23 | $1K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,509 | $953.32 |
| 71045 | Radiologic examination, chest; single view | <1% | 246 | $898.11 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 42 | $366.10 |
| 80076 | <1% | 654 | $321.16 | |
| 84484 | <1% | 754 | $220.22 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 164 | $204.83 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 473 | $202.39 |
| 81025 | <1% | 177 | $127.80 | |
| 85027 | <1% | 248 | $118.44 | |
| 81001 | <1% | 492 | $96.60 | |
| 87430 | <1% | 12 | $53.10 | |
| 83690 | <1% | 246 | $30.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 105 | $12.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $6.50 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 15 | $2.79 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 43 | $2.58 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 27 | $0.16 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 33 | $0.00 |
| A9270 | Non-covered item or service | 0% | 43 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 27 | $0.00 |
| 71275 | Computed tomographic angiography, chest, with contrast material | 0% | 14 | $0.00 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGALE, STEPHANIE (INTERIM CFO)
| Provider | Location | Paid |
|---|---|---|
| North Memorial Health Care | Brooklyn Center, MN | $112.83M |
| North Memorial Health Care | Robbinsdale, MN | $32.43M |
| North Memorial Health Care | Minnetonka, MN | $7.40M |
| North Memorial Health Care | Robbinsdale, MN | $5.62M |
| North Memorial Health Care | Maple Grove, MN | $4.55M |
| North Memorial Health Care | Robbinsdale, MN | $4.03M |
| Oakdale Health Enterprises, INC. | Alexandria, MN | $2.97M |
| North Memorial Health Care | Robbinsdale, MN | $2.19M |
| North Memorial Health Care | Robbinsdale, MN | $1.99M |
| North Memorial Health Care | Maple Grove, MN | $297K |
| Western Physical Therapy INC | Yuba City, CA | $126K |
| North Memorial Health Care | Robbinsdale, MN | $58K |
| Oakdale Health Enterprises INC | Park Rapids, MN | $28K |
| North Memorial Health Care | Robbinsdale, MN | $25K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.